Secondly, our analysis may underestimate progression of CKD in non-PKD2 cases due to ascertainment bias through exclusion of patients with existing CKD5/ESRD, since our results suggest a predominance of non-PKD2 in patients in this group. The gene discussed is PKD2; the disease is chronic kidney disease.